539267 Stock Overview
Operates as a bio-pharmaceutical company in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Samsrita Labs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹22.17 |
| 52 Week High | ₹32.36 |
| 52 Week Low | ₹13.00 |
| Beta | 0.026 |
| 11 Month Change | 6.18% |
| 3 Month Change | 28.08% |
| 1 Year Change | 36.01% |
| 33 Year Change | -13.57% |
| 5 Year Change | -69.10% |
| Change since IPO | 68.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| 539267 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | 15.2% | 3.9% | 2.9% |
| 1Y | 36.0% | 53.9% | 27.9% |
Return vs Industry: 539267 underperformed the Indian Life Sciences industry which returned 53.9% over the past year.
Return vs Market: 539267 exceeded the Indian Market which returned 27.9% over the past year.
Price Volatility
| 539267 volatility | |
|---|---|
| 539267 Average Weekly Movement | 11.7% |
| Life Sciences Industry Average Movement | 6.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 539267's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 539267's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 3 | Kalidindi Raju | drhlsl.com |
Samsrita Labs Limited operates as a bio-pharmaceutical company in India. The company offers DNA, RNA, and chromosomal based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and pre-natal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype and fluorescence in-situ hybridization analysis. It is also involved in stem cell research and therapy, including regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nano formulation of cancer drugs, molecular genetics, and molecular virology, as well as focuses on the body organs of liver, pancreas, neural, cardiac, vascular, renal, and ortho.
Samsrita Labs Limited Fundamentals Summary
| 539267 fundamental statistics | |
|---|---|
| Market cap | ₹328.31m |
| Earnings (TTM) | -₹2.60m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-126.4x
P/E RatioIs 539267 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 539267 income statement (TTM) | |
|---|---|
| Revenue | ₹0 |
| Cost of Revenue | ₹0 |
| Gross Profit | ₹0 |
| Other Expenses | ₹2.60m |
| Earnings | -₹2.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.18 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 19.1% |
How did 539267 perform over the long term?
See historical performance and comparison